1. Home
  2. JG vs KYNB Comparison

JG vs KYNB Comparison

Compare JG & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

N/A

Current Price

$7.00

Market Cap

38.9M

Sector

Technology

ML Signal

N/A

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$6.15

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JG
KYNB
Founded
2012
1993
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
32.8M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
JG
KYNB
Price
$7.00
$6.15
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $39.67
AVG Volume (30 Days)
2.6K
★ 28.0K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9552.08
EPS
★ N/A
N/A
Revenue
N/A
★ $6,440,000.00
Revenue This Year
N/A
$4.23
Revenue Next Year
N/A
$14.15
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.20
$5.62
52 Week High
$8.58
$9.58

Technical Indicators

Market Signals
Indicator
JG
KYNB
Relative Strength Index (RSI) 61.87 35.41
Support Level $6.25 N/A
Resistance Level $8.32 $7.41
Average True Range (ATR) 0.30 0.32
MACD 0.03 -0.08
Stochastic Oscillator 91.89 38.10

Price Performance

Historical Comparison
JG
KYNB

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates in one segment and generates revenues from SAAS Businesses.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: